• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Congenital Disorders of Glycosylation from a Neurological Perspective.从神经学角度看先天性糖基化障碍
Brain Sci. 2021 Jan 11;11(1):88. doi: 10.3390/brainsci11010088.
2
Clinical, neuroradiological, and biochemical features of SLC35A2-CDG patients.SLC35A2-CDG 患者的临床、神经放射学和生化特征。
J Inherit Metab Dis. 2019 May;42(3):553-564. doi: 10.1002/jimd.12055. Epub 2019 Feb 11.
3
Neurological Consequences of Congenital Disorders of Glycosylation.先天性糖基化障碍的神经学后果。
Adv Neurobiol. 2023;29:219-253. doi: 10.1007/978-3-031-12390-0_8.
4
Congenital disorders of glycosylation.先天性糖基化障碍
Handb Clin Neurol. 2013;113:1737-43. doi: 10.1016/B978-0-444-59565-2.00044-7.
5
Global serum glycoform profiling for the investigation of dystroglycanopathies & Congenital Disorders of Glycosylation.用于研究糖肌营养不良症和先天性糖基化障碍的全球血清糖型分析
Mol Genet Metab Rep. 2016 Apr 17;7:55-62. doi: 10.1016/j.ymgmr.2016.03.002. eCollection 2016 Jun.
6
Long-term outcomes in ALG13-Congenital Disorder of Glycosylation.ALG13-先天性糖基化障碍的长期预后。
Am J Med Genet A. 2023 Jun;191(6):1626-1631. doi: 10.1002/ajmg.a.63179. Epub 2023 Mar 17.
7
Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.西班牙非磷酸甘露糖变位酶 2 N-连接性先天性糖基化障碍的临床和分子诊断。
Clin Genet. 2019 May;95(5):615-626. doi: 10.1111/cge.13508. Epub 2019 Apr 3.
8
Electroclinical Features of Early-Onset Epileptic Encephalopathies in Congenital Disorders of Glycosylation (CDGs).糖基化先天性疾病(CDGs)中早发性癫痫性脑病的电临床特征。
JIMD Rep. 2016;27:93-9. doi: 10.1007/8904_2015_497. Epub 2015 Oct 10.
9
Dolichol kinase deficiency (DOLK-CDG) with a purely neurological presentation caused by a novel mutation.新型突变导致的单纯神经表现型多萜醇激酶缺乏症(DOLK-CDG)。
Mol Genet Metab. 2013 Nov;110(3):342-4. doi: 10.1016/j.ymgme.2013.07.002. Epub 2013 Jul 10.
10
DPAGT1-CDG: Report of Two New Pediatric Patients and Brief Review of the Literature.磷酸甘露糖基转移酶1缺陷型先天性糖基化障碍:两例新的儿科患者报告及文献简要综述
Mol Syndromol. 2023 Aug;14(4):322-330. doi: 10.1159/000529494. Epub 2023 Mar 8.

引用本文的文献

1
Uncommon Factors Leading to Nephrotic Syndrome.导致肾病综合征的罕见因素。
Biomedicines. 2025 Aug 5;13(8):1907. doi: 10.3390/biomedicines13081907.
2
Is dolichol pathway dysfunction a significant factor in Alzheimer's disease?多萜醇途径功能障碍是阿尔茨海默病的一个重要因素吗?
Inflammopharmacology. 2025 Jul 25. doi: 10.1007/s10787-025-01868-x.
3
Approaches to diagnostic screening for congenital disorders of glycosylation and its prevalence in Japan.先天性糖基化障碍的诊断筛查方法及其在日本的患病率
J Hum Genet. 2025 Jul 2. doi: 10.1038/s10038-025-01362-w.
4
A recurrent c.953A>C (p. Gln318Pro) variant in ALG11 causing congenital disorder of glycosylation in Turkish population.在土耳其人群中,ALG11基因中一个反复出现的c.953A>C(p.Gln318Pro)变异导致糖基化先天性疾病。
Neurogenetics. 2025 May 27;26(1):46. doi: 10.1007/s10048-025-00826-7.
5
The long way to diagnosis: attention disorder, alcohol addiction or congenital disorder of glycosylation? A case report.诊断的漫漫长路:注意缺陷障碍、酒精成瘾还是先天性糖基化障碍?一例报告
BMC Psychiatry. 2025 Apr 29;25(1):435. doi: 10.1186/s12888-025-06862-9.
6
Toward molecular phenotyping of temporal lobe epilepsy by spatial omics.通过空间组学实现颞叶癫痫的分子表型分析。
Epilepsia. 2025 Jul;66(7):2538-2553. doi: 10.1111/epi.18366. Epub 2025 Mar 20.
7
Causes of mortality in the congenital disorders of glycosylation.糖基化先天性疾病的死亡原因。
Mol Genet Metab. 2025 Mar;144(3):109052. doi: 10.1016/j.ymgme.2025.109052. Epub 2025 Feb 4.
8
Mapping the diagnostic odyssey of congenital disorders of glycosylation (CDG): insights from the community.绘制先天性糖基化障碍(CDG)的诊断之旅:来自社区的见解。
Orphanet J Rare Dis. 2024 Nov 1;19(1):407. doi: 10.1186/s13023-024-03389-2.
9
Advancements in Dravet Syndrome Therapeutics: A Comprehensive Look at Present and Future Treatment Horizons: A Focused Review.德雷维特综合征治疗进展:全面审视当前与未来的治疗前景:一篇聚焦综述
Ann Indian Acad Neurol. 2024 Jul 1;27(4):352-357. doi: 10.4103/aian.aian_49_24. Epub 2024 Aug 16.
10
Lowered GnT-I Activity Decreases Complex-Type N-Glycan Amounts and Results in an Aberrant Primary Motor Neuron Structure in the Spinal Cord.GnT-I活性降低会减少复合型N-聚糖的数量,并导致脊髓中初级运动神经元结构异常。
J Dev Biol. 2024 Aug 16;12(3):21. doi: 10.3390/jdb12030021.

本文引用的文献

1
Abstracts from the 53rd European Society of Human Genetics (ESHG) Conference: e-Posters.第53届欧洲人类遗传学学会(ESHG)会议摘要:电子海报
Eur J Hum Genet. 2020 Dec;28(Suppl 1):798-1016. doi: 10.1038/s41431-020-00741-5.
2
Epilepsy and movement disorders in CDG: Report on the oldest-known MOGS-CDG patient.脑白质糖脂代谢障碍合并癫痫和运动障碍:首例 MOGS-CDG 患者的报告。
Am J Med Genet A. 2021 Jan;185(1):219-222. doi: 10.1002/ajmg.a.61916. Epub 2020 Oct 15.
3
ALG13 participates in epileptogenesis via regulation of GABA receptors in mouse models.在小鼠模型中,ALG13通过调节GABA受体参与癫痫发生。
Cell Death Discov. 2020 Sep 17;6(1):87. doi: 10.1038/s41420-020-00319-6. eCollection 2020.
4
COG6-CDG: Expanding the phenotype with emphasis on glycosylation defects involved in the causation of male disorders of sex development.COG6-CDG:扩大表型,重点关注糖基化缺陷在男性性别发育障碍发病机制中的作用。
Clin Genet. 2020 Oct;98(4):402-407. doi: 10.1111/cge.13816. Epub 2020 Aug 4.
5
Predominant and novel de novo variants in 29 individuals with ALG13 deficiency: Clinical description, biomarker status, biochemical analysis, and treatment suggestions.29 例 ALG13 缺陷症患者的主要和新型新生变异:临床描述、生物标志物状态、生化分析和治疗建议。
J Inherit Metab Dis. 2020 Nov;43(6):1333-1348. doi: 10.1002/jimd.12290. Epub 2020 Aug 5.
6
Vertical nystagmus as a feature of PIGN-related glycosylphosphatidylinositol biosynthesis defects.垂直性眼球震颤为 PIGN 相关糖基磷脂酰肌醇生物合成缺陷的特征。
Clin Neurol Neurosurg. 2020 Sep;196:106033. doi: 10.1016/j.clineuro.2020.106033. Epub 2020 Jun 18.
7
ALG12-CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant.ALG12-CDG:一位不伴有智力残疾和面部畸形的不寻常患者,携带一种新的变异。
Mol Genet Genomic Med. 2020 Aug;8(8):e1304. doi: 10.1002/mgg3.1304. Epub 2020 Jun 12.
8
Lessons learned from 40 novel PIGA patients and a review of the literature.从 40 例新型 PIGA 患者中吸取的经验教训和文献回顾。
Epilepsia. 2020 Jun;61(6):1142-1155. doi: 10.1111/epi.16545. Epub 2020 May 26.
9
Successful treatment of intractable epilepsy with ketogenic diet therapy in twins with ALG3-CDG.双胞胎伴 ALG3-CDG 采用生酮饮食治疗难治性癫痫取得成功。
Brain Dev. 2020 Aug;42(7):539-545. doi: 10.1016/j.braindev.2020.04.008. Epub 2020 May 7.
10
Oligosaccharyltransferase complex-congenital disorders of glycosylation: A novel congenital disorder of glycosylation.寡糖基转移酶复合物-糖基化先天性疾病:一种新型的糖基化先天性疾病。
Am J Med Genet A. 2020 Jun;182(6):1460-1465. doi: 10.1002/ajmg.a.61553. Epub 2020 Apr 8.

从神经学角度看先天性糖基化障碍

Congenital Disorders of Glycosylation from a Neurological Perspective.

作者信息

Paprocka Justyna, Jezela-Stanek Aleksandra, Tylki-Szymańska Anna, Grunewald Stephanie

机构信息

Department of Pediatric Neurology, Faculty of Medical Science in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.

Department of Genetics and Clinical Immunology, National Institute of Tuberculosis and Lung Diseases, 01-138 Warsaw, Poland.

出版信息

Brain Sci. 2021 Jan 11;11(1):88. doi: 10.3390/brainsci11010088.

DOI:10.3390/brainsci11010088
PMID:33440761
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7827962/
Abstract

Most plasma proteins, cell membrane proteins and other proteins are glycoproteins with sugar chains attached to the polypeptide-glycans. Glycosylation is the main element of the post-translational transformation of most human proteins. Since glycosylation processes are necessary for many different biological processes, patients present a diverse spectrum of phenotypes and severity of symptoms. The most frequently observed neurological symptoms in congenital disorders of glycosylation (CDG) are: epilepsy, intellectual disability, myopathies, neuropathies and stroke-like episodes. Epilepsy is seen in many CDG subtypes and particularly present in the case of mutations in the following genes: , , , , , , , . On brain neuroimaging, atrophic changes of the cerebellum and cerebrum are frequently seen. Brain malformations particularly in the group of dystroglycanopathies are reported. Despite the growing number of CDG patients in the world and often neurological symptoms dominating in the clinical picture, the number of performed screening tests eg transferrin isoforms is systematically decreasing as broadened genetic testing is recently more favored. The aim of the review is the summary of selected neurological symptoms in CDG described in the literature in one paper. It is especially important for pediatric neurologists not experienced in the field of metabolic medicine. It may help to facilitate the diagnosis of this expanding group of disorders. Biochemically, this paper focuses on protein glycosylation abnormalities.

摘要

大多数血浆蛋白、细胞膜蛋白和其他蛋白质都是糖蛋白,其糖链连接在多肽聚糖上。糖基化是大多数人类蛋白质翻译后修饰的主要组成部分。由于糖基化过程对许多不同的生物学过程至关重要,患者会表现出多样的表型和症状严重程度。在先天性糖基化障碍(CDG)中最常观察到的神经症状有:癫痫、智力障碍、肌病、神经病和类中风发作。癫痫在许多CDG亚型中都可见,尤其在以下基因发生突变时出现: , , , , , , , 。在脑部神经影像学检查中,经常可见小脑和大脑的萎缩性改变。有报道称存在脑畸形,尤其是在糖肌营养不良症组中。尽管全球CDG患者数量不断增加,且临床症状中神经症状往往占主导,但随着最近更倾向于进行更广泛的基因检测,诸如转铁蛋白异构体等筛查试验的执行数量却在系统性减少。本综述的目的是在一篇论文中总结文献中描述的CDG中选定的神经症状。这对在代谢医学领域经验不足的儿科神经科医生尤为重要。它可能有助于促进对这一不断扩大的疾病群体的诊断。从生物化学角度来看,本文重点关注蛋白质糖基化异常。